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Summar~ 
Previously published data are displayed in a new manner and show 
that there is complete systemic a v a i l a b i l i t y  of oral doses of 23- 
47 g of ethanol (0.35-0.75 g/kg or 30-60 ml of 95% ethanol) in 
man when administered in the f a s ~ s t a t e  re l a t i ve  to an i n t ra -  
venous infusion of the same doses administered over a 2-hr period. 
A previous report by other authors that oral ethanol (0.15 g/kg) 
in man had a mean systemic a v a i l a b i l i t y  of only 29% is explained 
by the fact  that the subjects were fed one hour pr ior  to adminis- 
t ra t ion  of the alcohol and that the intravenous dose was infused 
over only a 20 minute period. 
In a recent a r t i c l e  in th is  journal Julkunen et al ( I )  reported that 
three male nonalcoholics administered ethanol (O.l~--g/-l~g) o r a l l y  one hour 
a f te r  a standard morning meal gave a mean area under the blood ethanol concen- 
t ra t ion- t ime curve (AUC) of 1.43 ± 0.65 mmol/(l x hr) versus a mean AUC of 
4.89 ± 0.4 mmol/(l x hr) when the same dose was infuse~-Tnt'r-avenously over a 
20 minute period - which gives an absolute systemic a v a i l a b i l i t y  of only 29.2%. 
In th is  a r t i c l e  some of the resul ts  obtained in previous studies (2-6) 
are presented in a new manner in order to show, with a larger number of sub- 
jects than used by Julkunen et al ( I ) ,  that under d i f f e ren t  conditions than 
they used, administrat ion o~th-anol  o ra l l y  at dose levels  in the social 
drinking range yielded AUC values essent ia l l y  ident ical  and sometimes even 
larger than those observed when the same doses were administered via i n t ra -  
venous infusion over a 2-hr period. When Michaelis-Menten el iminat ion kin- 
et ics are operative the rate of presentation of metabolizable compound to 
l i v e r  enzymes is a major determinant of systemic a v a i l a b i l i t y  (7-15). Theory 
indicates that when the rate of presentation is equal to or exceeds the max- 
imal rate of metabolism, Vm, then systemic a v a i l a b i l i t y  is,complete. We (2) 
have estimated the average V m of ethanol to be 8.7 g/hr (V m : 75 ~M/I/min 
based on a V d of 42 I )  in normal nonalcoholic male volunteers. Hence oral 
input rates equal to or greater than 8°7 g/hr should theo re t i ca l l y  lead to 
complete systemic b i o a v a i l a b i l i t y .  In addi t ion,  estimations made since publ i -  
cation of the or ig ina l  a r t i c l es  (2-6) indicate that the metabolic or i n t r i n s i c  
clearance of ethanol averages about Io5 L/min in man, which is the average 
value usual ly quoted for l i v e r  blood flow in man. This means that ,  using 
these average values, the b i o a v a i l a b i l i t y  of ethanol is 0°5 or 50% as the dose 
rate approaches zero and the b i o a v a i l a b i l i t y  increases gradual ly un t i l  the 
b i o a v a i l a b i l i t y  becomes 1.0 or 100% when the dose rate reaches 8.7 g/hr (13). 
These predict ions are based on the assumption that the input rate is the same 
for  intravenous and oral dosing. 
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Methods 
Human studies: Details of the studies have been reported in previous 
art icles (2-6). Study A (3): Six nonalcoholic male volunteers each were in- 
fused intravenously with 720 ml of 8% V/V ethanol in physiological saline over 
a 2-hr period; this provided a dose of 46 g (l mole) absolute ethanol, and 
since the panel had a mean body weight of 80.I kg, the mean dose was O.574g/kg. 
A seventh person (JW) was infused twice - once with same dose as above and, on 
the second occasion, with one-half the dose with respect to both the alcohol 
and volume infused over the 2-hr period. Capillary blood alcohol concentra- 
tions were measured by a head-space GLC method (5) at 29 sampling times over a 
0-7.75 hr period after each dose. Study B (2,4): Eight nonalcoholic male 
volunteers, weighing 74.6 kg (range 66-89 kg), were each administered doses of 
15, 30, 45 and 60 ml of 95% alcohol in orange juice (total volume 150 ml) 
after a lO hr fast in crossover fashion at l-week intervals° Only the 60 ml 
(approx. l mole or 0.608 g/kg) data are used in this ar t i c le .  A ninth person 
(JW) received 23.6 g (approx 0°5 mole or 0.372 g/kg) oral doses on two occa- 
sions and one 47.2 g (approx l mole or 0°743 g/kg) oral dose al l  under fasting 
conditions (6). After 60 ml doses the capil lary blood ethanol concentrations 
were measured by a head-space GLC method (5) at 38 sampling times over a 7-hr 
period, and after the lower doses given to JW t the capi l lary blood ethanol 
concentrations were measured by a GLC method (6) at 15 sampling times. 
AUC's were estimated by the trapezoidal rule. 
Results and Discussion 
Figure 1 is a plot of the mean capi l lary blood ethanol concentrations 
versus time for the six subjects given l mole of ethanol by intravenous infu- 
sion over a 2-hr period in Study A and for the eight subjects given s l ight ly  
less than l mole (45.4 g) oral ly in the fasting state. The AUC for the mean 
PO curve is 2o610 (mg/ml) x hr [56.7 (mmol/l)x hr], which is the same as the 
mean AUC of 2.611 (mg/ml) x hr of the 8 individual subject AUC's. The AUC 
for the mean IV curve is 2.284 (mg/ml) x hr [49.6 (mmol/l) x hr], which is 
essentially the same as the mean AUC of 2.279 (mg/ml) x hr of the 6 individual 
subject AUC's. Thus, the absolute systemic ava i lab i l i t y  estimated from the 
2,611 ~ mean AUC's of individual subjects i f  2.--T~F~x x I00 = I16%. This is valid 
since although the AUC-dose plot when Michaelis-Menten elimination kinetics 
are operative, is parabolic (8,21), i t  is reasonable to make a linear dose 
correction when the doses and AUC's are very close together. I t  should be 
noted in Figure l that the downslope elimination phases are essentially super- 
imposable, part icularly from 3.5 to 8 hours. The fact that the systemic 
ava i lab i l i t y  exceeds I00% may be explained by the fact that the input rate in 
the fasted subjects was considerably more rapid when the ethanol was given 
oral ly (peak concentration at l -hr)  than when the ethanol was infused I~Vo 
(peak concentration at 2-hr) and the operation of Michaelis-Menten elimination 
kinetics (8, 12, 18, 20, 21). In addition, the slope of the pseudo-linear 
elimination phase in the 3.5-5.5 hr period estimated from the PO mean data in 
Figure l is 0.166 mg/(ml x hr) [60.0 ~mol/1/min], and that estimated from the 
IV mean data is 0.162 mg/(ml x hr) [58.6 ~mol/I/min] - which are essentially 
identical to the 58 ~mol/I/min reported by Keiding et al (16) for ethanol 
elimination in nonalcoholics at a lO mmol/l concentra-'-t1~n. 
I 
The effect of input rate on AUC for ethanol was simulated by using a V m = 
0°202 mg/(ml x hr) and a K m value of 0.082 mg/ml, reported formerly as a result 
of f i t t i ng  data from Study B (4), and the model equation l with the Runge-Kutta 
numerical integration method and an Apple microcomputer, where C is the simu- 
lated concentration, V is the volume of distribution (taken as 40 l ) ,  Ro is 
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Comparison of mean capillary blood ethanol concentrations in non- 
alcoholic male subjects. 
Key:& Study B: 8 subjects given 45.4 g ethanol in fasting state orally° 
QStudy A: 6 subjects given 46 g ethanol ~ I.~.infusion over 2 hours. 
! 
dC Ro VmC 
~ = T "  ~'~--E Eq (I) 
the mass/time infusion rate, and Ro/V is the mass/(volume x time) input rate. 
R o was made operative over times (T) from 0 (bolus administration) to 2 hours. 
The area 0-T was estimated by trapezoidal rule. The area T-~ was estimated by 
equation 2 (17), 
C T [ ~ K  1 AUC T-~ = - T  + Eq (2) 
V m 
where C T is the concentrat ion at the end of the in fus ion at T hours. The two 
areas were than added to obtain AUC 0-~. The table below given the resu l ts  
of s imulat ions where the dose was 10.5 g ethanol (0.15 g/kg) as in the study of 
Julkunen et al ( I ) .  
The data in Table 1 ind icate that  the in fus ion time of 20 minutes used 
Julkunen et al ( I )  would make the i r ' I LV .  AUC r e l a t i v e l y  higher than the in fu -  
sion time-~-f-~-hours used in our Study Ao We have s'h'own that  both l i qu id  (18, 
19) and so l id  (20) foods reduce ethanol absorption rate and reduce ethanoIAUC'~ 
410 First-pass Ethanol Metabolism Vol. 39, No. 5, 1986 
TABLE l 
Auc's Obtained In The Input Rate Simulations 
vv 
Infusion ~ 
Tim~ T (Minutes) . . . .  x h 0 - T T - ~ 0 - 
0 . . . . . .  0.2769 
3 5.25 0.00642 0 .26589  0.2723 
6 2°265 0 . 0 1 2 6 3  0 .25759  0.2702 
9 l .75 0.01862 0 .24941 0.2680 
12 l .3125 0 .02439  0 .23976  0°2642 
15 1.05 0.02994 0 .23186  0.2618 
18 0°875 0 . 0 3 5 2 7  0 .22408  0.2594 
20 0.78758 0.03873 0 .21795  0.2567 
40 0.39379 0.06856 0 .17036  0.2389 
60 0.2625 0 . 0 9 0 8  0 . 1 3 2 9 9  0.2238 
120 0.13125 0.12335 0°06257 0o1859 
fD fD 
4 °  -~, 
~ 
( - f  
c-f 
fb 
The breakfast used by Julkunen et al (1) was essentially the same as the break- 
fast used as treatment C by Lin--et-a~ (20). When the oral ethanol dose (45 ml 
of 95% ethanol) was given with su-~'h~breakfast the AUC was reduced to 79.7 
(mg/ml) x hr compared with 213 (mg/ml) x hr in the same subjects under fasting 
conditions. Since such a fat ty breakfast empties slowly from the stomach i t  
is most probable that i t  slowed absorption of ethanol even though the ethanol 
was taken l hour after the breakfast in the study of Julkunen et al (1). Such 
a slower rate of absorption would result in the AUC being l oweFt~n that ob- 
tained for fasting conditions. 
Figure 2 shows results obtained in subject JWo AUC is plotted versus 
g/kg dose for two I~V. infusion doses and 4 oral treatments i n c l u d i n ~ e  
dif ferent doses° The least squares parabola forced through the origin, based 
on all 6 points is the l ine plotted in the Figure and conforms to theory of 
Michaelis-Menten kinetics (21). This plot strongly supports the lack of a 
first-pass effect. 
Figure 3 shows a plot of results obtained in Studies A and B. Again AUC 
is plotted Versus g/kg dose. There are 32 points corresponding to 4 oral doses 
in each of~-~u~-g~ects and 6 points corresponding to one'I.V, dose in 6 sub- 
jects. Again the least squares parabola forced through the origin based on all 
38 points is the l ine drawn through the points. Again, this plot strongly 
supports the lack of a first-pass effect. 
The parabolic relationships shown in Figures 2 and 3 indicate that the 
lower the dose of ethanol the lower the AUC/dose rat io. Thus, another reason 
why the AUC's reported by Julkunen et al (1) are relat ively much samller than 
those reported in this ar t ic le is t ~ w  dose they used relative to those we 
used. 
The results we obtained in 3 subjects (JW, RS and PW) who received both 
intravenous and oral doses at dif ferent times are summarized in Table I f .  
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FIG. 2 
Plot of AUC of blood ethanol concentrations versus g/kg dose of 
ethanol in nonalcoholic subject JW. 
Key: • Study B: 4 oral doses under fasting conditions. 
÷ Study A: 2 I.V. infusion doses given over 2 hours. 
Curve drawn through the points is the least squares parabola 
forced through the origin. 
The data obtained in rats by Julkunen et al (1) support our results in 
man. They reported a mean AUC of 8.71 (mmo~IT-x hr when ethanol was infused 
into the portal vein versus 7.94 (mmol/l) x hr when ethanol was administered 
intravenously. These data indicate no first-pass metabolism of ethanol in 
rats. However, when they administered the ethanol by intragastric intubation 
the mean AUC decreased to 1.74 (mmol/l) x hr. They appeared to explain this 
by alcohol dehydrogenase act iv i ty in the stomach° However this author knows 
of no evidence that ethanol is either metabolized by an enzyme nor chemically 
degraded in the stomach or intestine of man or the rat. 
Dedrick and Forrester (22) stated: "approaching the l imi t  of total ex- 
traction [of ethanol] by the l iver  the rate of oxidation [of ethanol] becomes 
dominated by hepatic blood flow and insensitive to the local enzyme kinetics." 
This partly explains our observations of lack of a first-pass effect at inter- 
mediate doses of ethanol. Keiding et al (16) reported a pseudo-linear decline 
of blood ethanol concentrations of ~ - ~ o l / I / m i n  in alcoholics following very 
high alcohol doses and in i t ia l  ethanol concentrations of 40-80 ~mol/l (2-4 
mg/ml), while nonalcoholics showed declines of 58 ~mole/I/min for in i t i a l  con- 
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centrations of lO mmol/l. As stated formerly the slopes of 60.0 and 58.6 
~mol/I/min estimated from the PO and IV data, respectively, in Figure l are 
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FIG. 3 
Plot of AUC of blood ethanol concentrations versus g/kg dose of ethanol. 
Key:O Study B: 4 different oral doses under ~ n g  conditions in 
8 nonalcoholic male subjects. 
"@-Study A: 46 g ethanol given in a volume of 720 ml by I.V. 
infusion over 2 hours. 
Julkunen et al (I) stated: "The magnitude of this FPM [f irst-pass met- 
abolism] deter~n~ the b ioavai labi l i ty  of alcohol and thus i ts  potential tox- 
i c i t y .  Prolonged alcohol abuse, by damaging the 'protective' gastrointestinal 
barrier, increases the bioavai labi l i ty  of ethanol, thereby enhancing the cen- 
tral  nervous system effects and the various toxic manifestations of ethanol in 
the alcoholic." This author believes this is a misleading and unfounded state- 
ment. Results reported in this ar t ic le  indicate that there is no first-pass 
effect when ethanol is administered in the social drinking dose range of 23-47 
g of ehtanol (30-60 ml of 95% alcohol). There can be no increased bioavail- 
ab i l i t y  of alcohol in alcoholics since nonalcoholics exhibit I00% or even 
greater systemic b ioavai labi l i ty .  Bioavai labi l i ty in excess of I00% is ex- 
plained in that the intravenous input rate is s igni f icant ly less than the in- 
put rate resulting from oral administration. 






TABLE II  
Indicating Lack of First-Pass Effect in Three Subjects When 
Subjects Fasted Prior to Oral Administration 
! 
Body AUC Vm Km 
Weight Dose ~4  ~ Sys temic  [ m - T ~  
(kg) Route (Grams) x h Bioavailability (mg/ml) 
66.2 ~l~V. 23.519 0.8385 -- 0.161 0.0208 
63.5 P;O. 23.6 0.8025 1 . 0 4  . . . .  
63.5 P.O. 23.6 0.7093 1 . 1 8  . . . .  
66.2 I .V .  44.327 2.917 -- 0.192 0.0335 
63°5 P.O. 47.2 3.072 0 ° 9 0  . . . .  
75.0 I~V. 46.545 1.941 -- 0.192 0.0302 
7 5 . 0  P.O.  45.00 2.968 1.58 . . . .  
79.6 l . V .  47.322 2°586 -- 0.238 0.0762 
79°5 P~Oo 45.00 3°249 1.31 . . . .  
Mean 1.20 
C.V.(%) 21.7 
I f  anything is l i fe  saving in man with respect to ethanol i t  is the 
effect of ethanol on stomach emptying. The larger the dose of ethanol the 
slower the stomach empties; this coupled with the operation of Michaelis- 
Menten elimination kinetics results in lower AUC's. This effect probably 
saves the lives of those foolish persons who ingest large amounts of ethanol 
all at once(4). The other very important factor is the type and amount of 
food taken with the alcohol. The more food one eats the slower the rate of 
absorption of the ethanol (most probably because of food slowing the rate of 
stomach emptying), the lower the AUC for a given dose and the less the state 
of inebriation (6, 18, 20). This author and his co-investigator (PKW) have 
had many test doses of ethanol accompanied by measurement of alcohol blood 
concentrations and can attest to the profound effect of food on blood ethanol 
concentrations and the sensory effects of alcohol. 
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